Update on the diagnosis and management of medullary thyroid cancer: what has changed in recent years?

K Kaliszewski, M Ludwig, B Ludwig, A Mikuła… - Cancers, 2022 - mdpi.com
Simple Summary Medullary thyroid carcinoma (MTC) is a rare neoplasm that is responsible
for a fair proportion of thyroid carcinoma related deaths. The current diagnostic and …

[HTML][HTML] Holomics and Artificial Intelligence-Driven Precision Oncology for Medullary Thyroid Carcinoma: Addressing Challenges of a Rare and Aggressive Disease

TE Luvhengo, MS Moeng, NT Sishuba, M Makgoka… - Cancers, 2024 - mdpi.com
Simple Summary Medullary thyroid carcinoma (MTC) is a rare but aggressive form of thyroid
cancer accounting for over 10% of deaths related to thyroid malignancies. MTC can be …

Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis

V Melone, A Salvati, D Palumbo, G Giurato… - Journal of translational …, 2022 - Springer
Abstract Background Neuroendocrine neoplasms (NENs) represent a heterogeneous class
of rare tumors with increasing incidence. They are characterized by the ability to secrete …

[HTML][HTML] Clinical value of complete blood count ratio in benign and malignant thyroid diseases

C Jiang, Y Wu, J Huang, Y Wang, H Cong - Cancer Epidemiology, 2024 - Elsevier
Objective To investigate the clinical value of blood routine derivative biomarkers and thyroid
function biomarkers in differentiating different thyroid diseases. Methods The differences of …

Medullary thyroid carcinoma: a narrative historical review

A Wong, K Nabata, SM Wiseman - Expert review of anticancer …, 2022 - Taylor & Francis
Introduction Sporadic or hereditary medullary thyroid carcinoma (MTC) is an uncommon
thyroid malignancy arising from calcitonin secreting parafollicular C cells. Interestingly, MTC …

Partial preservation of the normal thyroid gland based on tumor diameter may be possible in small medullary thyroid carcinoma: a two-center 15-year retrospective …

G Fu, X Li, F Guo, X Ruan, W Zhang, W Zhang… - Frontiers in …, 2023 - frontiersin.org
Background At present, there are some controversies in the formulation of surgical protocol
for small medullary thyroid carcinoma (s-MTC). We wanted to explore the feasibility of …

Evolution of thyroid cancer biomarkers: from laboratory test to patients' clinical management

ML Garo, A Campennì… - Clinical Chemistry and …, 2023 - degruyter.com
Over the past three decades, laboratory medicine has significantly evolved thanks to
technological advances made possible by new materials and evidence. Clinicians' ongoing …

Using preoperative ultrasound vascularity characteristics to estimate medullary thyroid cancer

L Gao, L Ma, X Li, C Liu, N Li, X Lian, W Xia, R Liu… - Cancer Imaging, 2023 - Springer
Background The early diagnosis of medullary thyroid carcinoma (MTC) is still a challenge in
clinical practice. Based on ultrasound features, many MTC cases without suspicious …

Effects of side chain and peptide bond modifications on the targeting properties of stabilized minigastrin analogs

TS Zavvar, AA Hörmann, M Klingler, D Summer… - Pharmaceuticals, 2023 - mdpi.com
Different attempts have been made in the past two decades to develop radiolabeled peptide
conjugates with enhanced pharmacokinetic properties in order to improve the application for …

Medullary Thyroid Cancer: Single Institute Experience over Three Decades and Risk Factors for Recurrence

S Abou Azar, J Tobias, M Applewhite… - The Journal of …, 2024 - academic.oup.com
Context Medullary thyroid cancer (MTC) has a historic recurrence rate up to 50%, and
surgery remains the only cure. Objective This study aims to assess factors related to …